News

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
Two new injectable drugs offer hope to the obese, especially diabetics, and could set off a pharma race to cash in on the ...
But the surge in Chinese pharma is still ringing alarm bells. “China’s rise in biotech is a threat to the United States,” ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
A new bill could make the price of prescription drugs known for weight loss cheaper for the state of Ohio to buy for its ...
At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...
Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss drug Wegovy. | Novo Nordisk is partnering with WeightWatchers to offer ...